GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Index / Blue Gene Biotech / Mouse Systemic RNA interference defective protein 2 /Product Detail : E03S0099 Mouse Systemic RNA interference defective protein 2
Related keywords:

#E03S0099 Mouse Systemic RNA interference defective protein 2

Ask technical file .

  Price : 843   EUR
956   USD
654   GBP
3541   Zloty
112794   JPY
6501   NOK
6965   SEK
953   CHF

Product name : Mouse Systemic RNA interference defective protein 2

Catalog number : E03S0099

Quantity: 96T/kit

Availability: Yes

Supplier name : Blue Gene Biotech

ask pdf gentaur products Data sheet : Ask more or other datasheet now !

About this Product :

Mouse Systemic RNA interference defective protein 2 rna research rna is not so stable and very sticky. Rnases are abundand on hans and everywhere. SoreRNA at -75C and use rnase free.
http://gentaur-search.com/save_search/rna.htm

Contact us about this product :

Our team will respond you as soon as possible !

Email :
Skype :
Name :
Phone :
address :
Question, Comment :
arrow security gentaurPlease retype this code below :
Blue_Gene_Biotech \ Mouse_Systemic_RNA_interference_defective_protein_2 \ E03S0099
Reload Image

Kits Elisa; taq POLYMERASE

Search in Google:

google

Share this page:
share on twitter rss feedsfacebookgoogle gentaur



Quick order!
Enter catalog number :


Gentaur; yes we can

Related products : Mouse Systemic RNA interference defective protein 2


Gentaurpub

Pathways :
WP1371: G Protein Signaling Pathways
WP394: RNA interference and miRNA
WP100: Glutathione metabolism
WP1039: Glutathione metabolism
WP104: Alanine and aspartate metabolism
WP1049: G Protein Signaling Pathways
WP106: Alanine and aspartate metabolism
WP1126: Tryptophan metabolism
WP1165: G Protein Signaling Pathways
WP1313: Insulin Signaling
WP1321: Myometrial Relaxation and Contraction Pathways
WP1323: EGFR1 Signaling Pathway
WP1329: Alpha6-Beta4 Integrin Signaling Pathway
WP1333: Hypothetical Network for Drug Addiction
WP1344: Wnt Signaling Pathway and Pluripotency
WP1345: T Cell Receptor Signaling Pathway
WP1348: Androgen Receptor Signaling Pathway
WP1354: B Cell Receptor Signaling Pathway
WP1355: One Carbon Metabolism
WP1362: Homologous recombination
WP1363: p38 MAPK Signaling Pathway
WP1365: Calcium Regulation in the Cardiac Cell
WP1370: TGF Beta Signaling Pathway
WP1373: GPCRs, Class C Metabotropic glutamate, pheromone
WP1378: Senescence and Autophagy

Related Genes :
[sid-1 C04F5.1] Systemic RNA interference defective protein 1 (Systemic RNAi enabling protein)
[sid-3 B0302.1] Tyrosine-protein kinase sid-3 (EC 2.7.10.2) (Systemic RNA interference defective protein 3) (Systemic RNAi enabling protein)
[sid-2 ZK520.2] Systemic RNA interference defective protein 2
[NRPD1 NRPD1a RMD3 RPD1 SDE4 SMD2 At1g63020 F16M19.19 F16P17.19] DNA-directed RNA polymerase IV subunit 1 (DNA-directed RNA polymerase D subunit 1) (AtNRPD1a) (Nuclear RNA polymerase D 1a) (EC 2.7.7.6) (Protein RNA-DIRECTED DNA METHYLATION DEFECTIVE 3) (Protein SILENCING DEFECTIVE 4) (Protein SILENCING MOVEMENT DEFICIENT 2) (RNA polymerase IV subunit 1a) (POL IV 1a)
[NRPD2 DMS2 DRD2 NRPD2a NRPE2 RPD2a At3g23780 MYM9.13] DNA-directed RNA polymerases IV and V subunit 2 (EC 2.7.7.6) (DNA-directed RNA polymerase D subunit 2a) (AtNRPD2a) (Nuclear RNA polymerase D 2a) (Nuclear RNA polymerase E 2) (Protein DEFECTIVE IN MERISTEM SILENCING 2) (Protein DEFECTIVE IN RNA-DIRECTED DNA METHYLATION 2) (RNA polymerase IV subunit 2a) (POL IV 2a)
[NRPE1 DMS5 DRD3 NRPD1b RMD1 RPE1 At2g40030 T28M21.19] DNA-directed RNA polymerase V subunit 1 (DNA-directed RNA polymerase D subunit 1b) (AtNRPD1b) (Nuclear RNA polymerase D 1b) (DNA-directed RNA polymerase E subunit 1) (Nuclear RNA polymerase E 1) (EC 2.7.7.6) (Protein DEFECTIVE IN MERISTEM SILENCING 5) (Protein DEFECTIVE IN RNA-DIRECTED DNA METHYLATION 3) (Protein RNA-DIRECTED DNA METHYLATION DEFECTIVE 1) (RNA polymerase IV subunit 1) (POL IV 1)
[DRD1 CHR35 DMS1 At2g16390 F16F14.11] Protein CHROMATIN REMODELING 35 (Protein DEFECTIVE IN MERISTEM SILENCING 1) (Protein DEFECTIVE IN RNA-DIRECTED DNA METHYLATION 1)
[sid-5 F14B8.2] Systemic RNA interference defective protein 5
[RDR6 RDRP6 SDE1 SGS2 At3g49500 T1G12.20 T9C5.95] RNA-dependent RNA polymerase 6 (AtRDRP6) (EC 2.7.7.48) (Protein SILENCING DEFECTIVE 1) (Protein SUPPRESSOR OF GENE SILENCING 2) (RNA-directed RNA polymerase 6)
[rde-12 F58G11.2] DEAD-box ATP-dependent RNA helicase rde-12 (EC 3.6.4.13) (RNA interference defective protein 12)
[NRPB2 EMB1989 RP140 RPB135 RPB2 At4g21710 F17L22.170] DNA-directed RNA polymerase II subunit 2 (DNA-directed RNA polymerase II 135 kDa polypeptide) (DNA-directed RNA polymerase II subunit RPB2) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) (EC 2.7.7.6) (Protein EMBRYO DEFECTIVE 1989)
[CUV EMB3011 PINP1 At5g13010 T24H18_180] Pre-mRNA-splicing factor ATP-dependent RNA helicase DEAH7 (EC 3.6.4.13) (DEAH RNA helicase homolog PRP16) (Protein CLUMSY VEIN) (Protein EMBRYO DEFECTIVE 3011) (Protein PSR1-INTERACTING PROTEIN 1)
[ISE2 EMB25 PDE317 At1g70070 F20P5.20] DExH-box ATP-dependent RNA helicase DExH15 chloroplastic (EC 3.6.4.13) (ATP-dependent RNA helicase ISE2) (Protein EMBRYO DEFECTIVE 25) (Protein INCREASED SIZE EXCLUSION LIMIT 2) (Protein PIGMENT DEFECTIVE 317)
[] Genome polyprotein [Cleaved into: Capsid protein C (Core protein); Protein prM; Peptide pr; Small envelope protein M (Matrix protein); Envelope protein E; Non-structural protein 1 (NS1); Non-structural protein 2A (NS2A); Non-structural protein 2A-alpha (NS2A-alpha); Serine protease subunit NS2B (Flavivirin protease NS2B regulatory subunit) (Non-structural protein 2B); Serine protease NS3 (EC 3.4.21.91) (EC 3.6.1.15) (EC 3.6.4.13) (Flavivirin protease NS3 catalytic subunit) (Non-structural protein 3); Non-structural protein 4A (NS4A); Peptide 2k; Non-structural protein 4B (NS4B); RNA-directed RNA polymerase NS5 (EC 2.1.1.56) (EC 2.1.1.57) (EC 2.7.7.48) (Non-structural protein 5)]
[ago1 csp9 SPCC736.11] Protein argonaute (Cell cycle control protein ago1) (Eukaryotic translation initiation factor 2C 2-like protein ago1) (PAZ Piwi domain protein ago1) (Protein slicer) (RNA interference pathway protein ago1)
[Tarbp2 Prbp] RISC-loading complex subunit TARBP2 (Protamine-1 RNA-binding protein) (PRM-1 RNA-binding protein) (TAR RNA-binding protein 2)
[SUV3 EDA15 PDD17 PDD26 At4g14790 dl3435c FCAALL.309] DExH-box ATP-dependent RNA helicase DExH16, mitochondrial (EC 3.6.4.13) (ATP-dependent RNA helicase SUV3) (AtSUV3) (Protein EMBRYO SAC DEVELOPMENT ARREST 15) (Protein POLLEN DEVELOPMENT DEFECTIVE 17) (Protein POLLEN DEVELOPMENT DEFECTIVE 26) (Protein SUPPRESSOR OF VAR 3)
[BRR2A EMB1507 At1g20960 F9H16.5] DExH-box ATP-dependent RNA helicase DExH12 (EC 3.6.4.13) (BRR2 homolog A) (AtBRR2A) (Pre-mRNA-splicing helicase BRR2A) (Protein EMBRYO DEFECTIVE 1507)
[Ifitm3] Interferon-induced transmembrane protein 3 (Dispanin subfamily A member 2b) (DSPA2b) (Fragilis protein) (Interferon-inducible protein 15) (Mouse ifitm-like protein 1) (Mil-1)
[Pard3b Als2cr19 Par3l] Partitioning defective 3 homolog B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 19 protein homolog) (PAR3-beta) (Partitioning defective 3-like protein) (PAR3-L protein)
[Ifitm1] Interferon-induced transmembrane protein 1 (Dispanin subfamily A member 2a) (DSPA2a) (Fragilis protein 2) (Mouse ifitm-like protein 2) (Mil-2)
[Eif2ak2 Pkr Prkr Tik] Interferon-induced, double-stranded RNA-activated protein kinase (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 2) (eIF-2A protein kinase 2) (Interferon-inducible RNA-dependent protein kinase) (P1/eIF-2A protein kinase) (Protein kinase RNA-activated) (PKR) (Protein kinase R) (Serine/threonine-protein kinase TIK) (Tyrosine-protein kinase EIF2AK2) (EC 2.7.10.2) (p68 kinase)
[ESP3 EMB2733 At1g32490 F5D14.27] Pre-mRNA-splicing factor ATP-dependent RNA helicase DEAH1 (EC 3.6.4.13) (DEAH RNA helicase homolog PRP2) (Protein EMBRYO DEFECTIVE 2733) (Protein ENHANCED SILENCING PHENOTYPE 3)
[Dhx9 Ddx9] ATP-dependent RNA helicase A (EC 3.6.4.13) (DEAH box protein 9) (mHEL-5) (Nuclear DNA helicase II) (NDH II) (RNA helicase A) (RHA)
[Cacna1c Cach2 Cacn2 Cacnl1a1 Cchl1a1] Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (MELC-CC) (Mouse brain class C) (MBC) (Voltage-gated calcium channel subunit alpha Cav1.2)
[Rbfox2 Fox2 Fxh Hrnbp2 Rbm9] RNA binding protein fox-1 homolog 2 (Fox-1 homolog B) (Fox-1 homolog Fxh) (Hexaribonucleotide-binding protein 2) (RNA-binding motif protein 9) (RNA-binding protein 9)
[POL2A ABO4 EMB142 EMB2284 EMB529 ESD7 TIL1 At1g08260 T23G18.21] DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase 2 a) (AtPOL2a) (DNA polymerase II subunit a) (Protein ABA OVERLY SENSITIVE a) (Protein EARLY IN SHORT DAYS 7) (Protein EMBRYO DEFECTIVE 142) (Protein EMBRYO DEFECTIVE 2284) (Protein EMBRYO DEFECTIVE 529) (Protein TILTED 1)
[DEK1 EMB1275 EMB80 At1g55350 F7A10.23] Calpain-type cysteine protease DEK1 (EC 3.4.22.-) (Phytocalpain DEK1) (Protein DEFECTIVE KERNEL 1) (AtDEK1) (Protein EMBRYO DEFECTIVE 1275) (Protein EMBRYO DEFECTIVE 80)
[Adar] Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) (RNA adenosine deaminase 1)
[RDR2 RDRP2 SMD1 At4g11130 F2P3.11] RNA-dependent RNA polymerase 2 (AtRDRP2) (EC 2.7.7.48) (Protein SILENCING MOVEMENT DEFICIENT 1) (RNA-directed RNA polymerase 2)

Bibliography :
[27846365] Lysosomal membrane protein SIDT2 mediates the direct uptake of DNA by lysosomes.
[27746126] Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution.
[24838286] A C. elegans model of human α1-antitrypsin deficiency links components of the RNAi pathway to misfolded protein turnover.
[24651677] Disturbed flow promotes endothelial senescence via a p53-dependent pathway.
[24167251] Ctr2 regulates biogenesis of a cleaved form of mammalian Ctr1 metal transporter lacking the copper- and cisplatin-binding ecto-domain.
[23811849] Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists.
[20519932] Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation.
[17434453] Ectopic expression of systemic RNA interference defective protein in embryonic stem cells.
[15711641] Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism.